Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
1.
Journal of Zhejiang University. Science. B ; (12): 327-340, 2020.
Article Dans Anglais | WPRIM | ID: wpr-1010538

Résumé

Combined radiation-wound injury (CRWI) is characterized by blood vessel damage and pro-inflammatory cytokine deficiency. Studies have identified that the direct application of leptin plays a significant role in angiogenesis and inflammation. We established a sustained and stable leptin expression system to study the mechanism. A lentivirus method was employed to explore the angiogenic potential and peripheral inflammation of irradiated human umbilical vein endothelial cells (HUVECs). Leptin was transfected into human placenta-derived mesenchymal stem cells (HPMSCs) with lentiviral vectors. HUVECs were irradiated by X-ray at a single dose of 20 Gy. Transwell migration assay was performed to assess the migration of irradiated HUVECs. Based on the Transwell systems, co-culture systems of HPMSCs and irradiated HUVECs were established. Cell proliferation was measured by cell counting kit-8 (CCK-8) assay. The secretion of pro-inflammatory cytokines (human granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin (IL)-1α, IL-6, and IL-8) was detected by enzyme-linked immunosorbent assay (ELISA). The expression of pro-angiogenic factors (vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)) mRNA was detected by real-time quantitative polymerase chain reaction (RT-qPCR) assay. Relevant molecules of the nuclear factor-κB (NF-κB) and Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathways were detected by western blot assay. Results showed that leptin-modified HPMSCs (HPMSCs/ leptin) exhibited better cell proliferation, migration, and angiogenic potential (expressed more VEGF and bFGF). In both the single HPMSCs/leptin and the co-culture systems of HPMSCs/leptin and irradiated HUVECs, the increased secretion of pro-inflammatory cytokines (human GM-CSF, IL-1α, and IL-6) was associated with the interaction of the NF-κB and JAK/STAT signaling pathways. We conclude that HPMSCs/leptin could promote angiogenic potential and peripheral inflammation of HUVECs after X-ray radiation.


Sujets)
Femelle , Humains , Grossesse , Prolifération cellulaire , Cellules cultivées , Cytokines/biosynthèse , Cellules endothéliales de la veine ombilicale humaine/effets des radiations , Inflammation/étiologie , Leptine/pharmacologie , Cellules souches mésenchymateuses/physiologie , Néovascularisation physiologique/physiologie , Placenta/cytologie , Facteur de transcription STAT-3/génétique , Facteur de transcription RelA/génétique , Rayons X
2.
Braz. j. med. biol. res ; 46(8): 696-699, ago. 2013. graf
Article Dans Anglais | LILACS | ID: lil-684534

Résumé

We investigated the effect of fish oil (FO) supplementation on tumor growth, cyclooxygenase 2 (COX-2), peroxisome proliferator-activated receptor gamma (PPARγ), and RelA gene and protein expression in Walker 256 tumor-bearing rats. Male Wistar rats (70 days old) were fed with regular chow (group W) or chow supplemented with 1 g/kg body weight FO daily (group WFO) until they reached 100 days of age. Both groups were then inoculated with a suspension of Walker 256 ascitic tumor cells (3×107 cells/mL). After 14 days the rats were killed, total RNA was isolated from the tumor tissue, and relative mRNA expression was measured using the 2-ΔΔCT method. FO significantly decreased tumor growth (W=13.18±1.58 vs WFO=5.40±0.88 g, P<0.05). FO supplementation also resulted in a significant decrease in COX-2 (W=100.1±1.62 vs WFO=59.39±5.53, P<0.001) and PPARγ (W=100.4±1.04 vs WFO=88.22±1.46, P<0.05) protein expression. Relative mRNA expression was W=1.06±0.022 vs WFO=0.31±0.04 (P<0.001) for COX-2, W=1.08±0.02 vs WFO=0.52±0.08 (P<0.001) for PPARγ, and W=1.04±0.02 vs WFO=0.82±0.04 (P<0.05) for RelA. FO reduced tumor growth by attenuating inflammatory gene expression associated with carcinogenesis.


Sujets)
Animaux , Mâle , /génétique , Prolifération cellulaire/effets des médicaments et des substances chimiques , /génétique , Huiles de poisson/pharmacologie , Récepteur PPAR gamma/génétique , Facteur de transcription RelA/génétique , /métabolisme , Compléments alimentaires , Acide docosahexaénoïque/pharmacologie , Acide eicosapentanoïque/pharmacologie , Huiles de poisson/composition chimique , Inhibiteurs de croissance/pharmacologie , Immunotransfert , Rat Wistar , Réaction de polymérisation en chaine en temps réel , Transcription génétique/effets des médicaments et des substances chimiques
3.
Experimental & Molecular Medicine ; : 429-439, 2009.
Article Dans Anglais | WPRIM | ID: wpr-196694

Résumé

Small heterodimer partner (SHP) is an atypical member of nuclear receptor superfamily that lacks a DNA-binding domain. In previous study, we showed that SHP, c-jun, p65 of NF-kappaB subunits, and p21WAF1 expression was increased during monocytic differentiaton with the exposure of human leukemia cells to a differentiation agent, PMA. In this study, c-Jun and p65 were shown to mediate the transcriptional activation of the SHP promoter. In addition, SHP induced the cell cycle regulatory protein levels and cooperatively increased an induction of p21WAF1 expression with p65. Furthermore, SHP protected differentiated cells from etoposide-induced cellular apoptosis through the induction and cytoplasmic sequestration of p21WAF1. Complex formation between SHP and p21WAF1 was demonstrated by means of coimmunoprecipitation. These results suggest that SHP prolongs a cellular survival of differentiating monocytes through the transcriptional regulation of target genes of cell survival and differentiation.


Sujets)
Humains , Apoptose , Différenciation cellulaire , Lignée cellulaire tumorale , Inhibiteur p21 de kinase cycline-dépendante/génétique , Régulation de l'expression des gènes , Monocytes/cytologie , Régions promotrices (génétique) , Protéines proto-oncogènes c-jun/génétique , Récepteurs cytoplasmiques et nucléaires/génétique , Facteur de transcription RelA/génétique
SÉLECTION CITATIONS
Détails de la recherche